Hayashi T, Su TP (2007). „Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival.”. Cell131 (3): 596–610. DOI:10.1016/j.cell.2007.08.036. PMID17981125.
Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V (December 1996). „Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)”. Biochem. Biophys. Res. Commun.229 (2): 553–8. DOI:10.1006/bbrc.1996.1842. PMID8954936.
Prasad PD, Li HW, Fei YJ, Ganapathy ME, Fujita T, Plumley LH, Yang-Feng TL, Leibach FH, Ganapathy V (February 1998). „Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene”. J. Neurochem.70 (2): 443–51. DOI:10.1046/j.1471-4159.1998.70020443.x. PMID9453537.
Guitart X, Codony X, Monroy X (2004). „Sigma receptors: biology and therapeutic potential”. Psychopharmacology (Berl.)174 (3): 301–19. DOI:10.1007/s00213-004-1920-9. PMID15197533.
Zhang H, Cuevas J (2005). „sigma Receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons”. J. Pharmacol. Exp. Ther.313 (3): 1387–96. DOI:10.1124/jpet.105.084152. PMID15764734.
Su TP, Hayashi T (2003). „Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction”. Curr. Med. Chem.10 (20): 2073–80. DOI:10.2174/0929867033456783. PMID12871086.
Zampieri D, Grazia Mamolo M, Laurini E, et al (January 2009). „Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site”. Eur J Med Chem44 (1): 124–30. DOI:10.1016/j.ejmech.2008.03.011. PMID18440098.
Große Maestrup E, Wiese C, Schepmann D, et al (April 2009). „Synthesis of spirocyclic sigma(1) receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability”. Bioorg. Med. Chem.17 (10): 3630. DOI:10.1016/j.bmc.2009.03.060. PMID19394833.
Hayashi T, Su TP (2007). „Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival.”. Cell131 (3): 596–610. DOI:10.1016/j.cell.2007.08.036. PMID17981125.
Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V (December 1996). „Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)”. Biochem. Biophys. Res. Commun.229 (2): 553–8. DOI:10.1006/bbrc.1996.1842. PMID8954936.
Prasad PD, Li HW, Fei YJ, Ganapathy ME, Fujita T, Plumley LH, Yang-Feng TL, Leibach FH, Ganapathy V (February 1998). „Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene”. J. Neurochem.70 (2): 443–51. DOI:10.1046/j.1471-4159.1998.70020443.x. PMID9453537.
Weissman AD, Su TP, Hedreen JC, London ED (1988). „Sigma receptors in post-mortem human brains”. J. Pharmacol. Exp. Ther.247 (1): 29–33. PMID2845055.
Guitart X, Codony X, Monroy X (2004). „Sigma receptors: biology and therapeutic potential”. Psychopharmacology (Berl.)174 (3): 301–19. DOI:10.1007/s00213-004-1920-9. PMID15197533.
Zhang H, Cuevas J (2005). „sigma Receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons”. J. Pharmacol. Exp. Ther.313 (3): 1387–96. DOI:10.1124/jpet.105.084152. PMID15764734.
Su TP, Hayashi T (2003). „Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction”. Curr. Med. Chem.10 (20): 2073–80. DOI:10.2174/0929867033456783. PMID12871086.
Zampieri D, Grazia Mamolo M, Laurini E, et al (January 2009). „Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site”. Eur J Med Chem44 (1): 124–30. DOI:10.1016/j.ejmech.2008.03.011. PMID18440098.
Große Maestrup E, Wiese C, Schepmann D, et al (April 2009). „Synthesis of spirocyclic sigma(1) receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability”. Bioorg. Med. Chem.17 (10): 3630. DOI:10.1016/j.bmc.2009.03.060. PMID19394833.